Alick-Lindstrom S, Weingarten M, Falco-Walter J, Gidal B, Abramowitz J, Lane C
Epilepsy Curr. 2025; :15357597251317908.
PMID: 40040857
PMC: 11873854.
DOI: 10.1177/15357597251317908.
Yao N, Zhao Q, Cao Y, Gu D, Zhang N
Pharm Res. 2025; 42(1):79-91.
PMID: 39843764
DOI: 10.1007/s11095-025-03817-3.
Stern J, Stanton S, Howe-Martin L, Lane C, Sports C, Gidal B
Epilepsy Curr. 2024; :15357597241242250.
PMID: 39554270
PMC: 11561941.
DOI: 10.1177/15357597241242250.
Barrionuevo E, Peralta E, Manzur De Nardi A, Monat J, Fallico M, Llanos M
Pharmaceutics. 2024; 16(8).
PMID: 39204342
PMC: 11357650.
DOI: 10.3390/pharmaceutics16080996.
Sun M, Zhang F, Lu F, Yu D, Wang Y, Chen P
Front Pharmacol. 2024; 15:1358626.
PMID: 38379898
PMC: 10877013.
DOI: 10.3389/fphar.2024.1358626.
Migraine - a borderland disease to epilepsy: near it but not of it.
Paungarttner J, Quartana M, Patti L, Sklenarova B, Farham F, Jimenez I
J Headache Pain. 2024; 25(1):11.
PMID: 38273253
PMC: 10811828.
DOI: 10.1186/s10194-024-01719-0.
Real-world antiseizure medication treatment outcomes in drug-resistant focal epilepsy patients.
Hatoum H, Arcona S, Mao J, Walton S
Epilepsia Open. 2023; 8(4):1556-1565.
PMID: 37842746
PMC: 10690664.
DOI: 10.1002/epi4.12845.
Investigating the Impact of Epilepsy on Cognitive Function: A Narrative Review.
Hoxhaj P, Habiya S, Sayabugari R, Balaji R, Xavier R, Ahmad A
Cureus. 2023; 15(6):e41223.
PMID: 37525802
PMC: 10387362.
DOI: 10.7759/cureus.41223.
Racial and Ethnic Differences in Antiseizure Medications Among People With Epilepsy on Medicaid: A Case of Potential Inequities.
Bensken W, Fernandez Baca Vaca G, Alberti P, Khan O, Ciesielski T, Jobst B
Neurol Clin Pract. 2023; 13(1):e200101.
PMID: 36865639
PMC: 9973322.
DOI: 10.1212/CPJ.0000000000200101.
Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy: An Observational Cohort Study.
van der Meer P, Dirven L, Fiocco M, Vos M, Kouwenhoven M, van den Bent M
Neurology. 2023; 100(14):e1488-e1496.
PMID: 36754633
PMC: 10104607.
DOI: 10.1212/WNL.0000000000206852.
Isobolographic analysis of adjunct antiseizure activity of the FDA-approved cannabidiol with neurosteroids and benzodiazepines in adult refractory focal onset epilepsy.
Golub V, Ramakrishnan S, Reddy D
Exp Neurol. 2022; 360:114294.
PMID: 36493860
PMC: 9884179.
DOI: 10.1016/j.expneurol.2022.114294.
A framework for health equity in people living with epilepsy.
Bensken W, Alberti P, Khan O, Williams S, Stange K, Vaca G
Epilepsy Res. 2022; 188:107038.
PMID: 36332544
PMC: 9797034.
DOI: 10.1016/j.eplepsyres.2022.107038.
Inconsistent Medicaid Coverage is Associated with Negative Health Events for People with Epilepsy.
Bensken W, Ciesielski T, Williams S, Stange K, Sajatovic M, Koroukian S
J Health Care Poor Underserved. 2022; 33(2):1036-1053.
PMID: 35574892
PMC: 9147776.
DOI: 10.1353/hpu.2022.0079.
Stroke and Ischemic Heart Disease With Enzyme-inducing Antiseizure Medications: Time to Change Prescribing Habits.
Vossler D
Epilepsy Curr. 2022; 22(2):120-122.
PMID: 35444497
PMC: 8988723.
DOI: 10.1177/15357597211070392.
'Channeling' therapeutic discovery for epileptic encephalopathy through iPSC technologies.
Simkin D, Ambrosi C, Marshall K, Williams L, Eisenberg J, Gharib M
Trends Pharmacol Sci. 2022; 43(5):392-405.
PMID: 35427475
PMC: 9119009.
DOI: 10.1016/j.tips.2022.03.001.
Cognitive Impairment in People with Epilepsy.
Novak A, Vizjak K, Rakusa M
J Clin Med. 2022; 11(1).
PMID: 35012007
PMC: 8746065.
DOI: 10.3390/jcm11010267.
Clinical and Economic Outcomes of Intravenous Brivaracetam Compared With Levetiracetam for the Treatment of Seizures in United States Hospitals.
Beaty S, Rosenthal N, Gayle J, Dongre P, Ricchetti-Masterson K
Front Neurol. 2021; 12:760855.
PMID: 34912285
PMC: 8667030.
DOI: 10.3389/fneur.2021.760855.
Seizure Management in the Intensive Care Unit.
Boggs J
Curr Treat Options Neurol. 2021; 23(11):36.
PMID: 34697528
PMC: 8528936.
DOI: 10.1007/s11940-021-00692-2.
High-Frequency Oscillations and Epileptogenic Network.
Li X, Zhang H, Lai H, Wang J, Wang W, Yang X
Curr Neuropharmacol. 2021; 20(9):1687-1703.
PMID: 34503414
PMC: 9881061.
DOI: 10.2174/1570159X19666210908165641.
Pharmacokinetic Drug-Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients.
Karazniewicz-Lada M, Glowka A, Mikulska A, Glowka F
Int J Mol Sci. 2021; 22(17).
PMID: 34502487
PMC: 8431452.
DOI: 10.3390/ijms22179582.
